iifl-logo

LIC MF Healthcare Fund Regular G

LIC MF Healthcare Fund Regular G

Fund Name

LIC Mutual Fund

Scheme Name

LIC MF Healthcare Fund Regular G

AMC

LIC Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

08-Feb-2019

Fund Manager

Karan Doshi

Net Assets (Rs. cr)

83.12

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

LIC MF Healthcare Fund Regular G - Nav Details

Nav Date

:  20-Jan-2026

NAV [Rs.]

:  27.7925

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.

LIC MF Healthcare Fund Regular G- NAV Chart

LIC MF Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-4.18
-4.66
-7.9
-7.06
-4.71
18.62
10.67
15.97
Category Avg
-3.63
-4.32
-6.65
-6.75
-3.1
21.53
14.5
11.82
Category Best
-1.8
-1.42
-1.34
-3.63
2.66
26.79
17.08
25.96
Category Worst
-4.27
-5.99
-10.37
-11.09
-9.89
16.64
10.68
-8.91

LIC MF Healthcare Fund Regular G- Latest Dividends

No Records Found

LIC MF Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

500

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Linde India1,559

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.85524369.01
EquityTorrent Pharma.Pharmaceuticals & Biotechnology6.08131305.05
EquityApollo HospitalsHealthcare Services5.7067234.73
EquityCiplaPharmaceuticals & Biotechnology5.68312184.71
EquityDivi's Lab.Pharmaceuticals & Biotechnology4.7461583.93
EquityNeuland Labs.Pharmaceuticals & Biotechnology4.5124683.74
EquityFortis Health.Healthcare Services4.48421023.72
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.46313013.70
EquityPiramal PharmaPharmaceuticals & Biotechnology4.322083513.58
EquityOneSource Speci.Pharmaceuticals & Biotechnology3.88178283.22
EquityAbbott IndiaPharmaceuticals & Biotechnology3.389682.80
EquityAlkem LabPharmaceuticals & Biotechnology3.3250082.75
EquityConcord BiotechPharmaceuticals & Biotechnology3.15194742.62
EquityArtemis MedicareHealthcare Services3.05935292.53
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.94119942.44
EquityNavin Fluo.Intl.Chemicals & Petrochemicals2.9341162.43
EquityIpca Labs.Pharmaceuticals & Biotechnology2.83166042.35
EquityGland PharmaPharmaceuticals & Biotechnology2.77133512.29
EquityMetropolis HealtHealthcare Services2.65114172.20
EquityDr Agarwal's HeaHealthcare Services2.42395762.01
EquityMankind PharmaPharmaceuticals & Biotechnology2.2785771.88
EquitySyngene Intl.Healthcare Services2.21282601.83
EquityGlobal HealthHealthcare Services2.13149521.77
EquityMax HealthcareHealthcare Services2.11167751.75
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.80229611.49
EquityAcutaas ChemicalPharmaceuticals & Biotechnology1.7083021.41
EquityVinati OrganicsChemicals & Petrochemicals1.6787411.38

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
44,894.42
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP

OTHER INFORMATION

Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.